The NHS is under pressure to award a £480 million contract for managing the data of millions of patients to a British start-up with noble intentions, rather than a US tech company with ties to espionage.
Quantexa, recently valued at over a billion dollars, is vying for a contract to integrate hospital data, a crucial step for improving healthcare and research. However, there are growing concerns among senior doctors regarding potential public backlash, especially considering that Palantir, a software company with strong connections to the US defense industry, is the leading contender for the contract.
Vishal Marria, CEO of Quantexa, advocated for the NHS to choose a British company whose staff have close ties to the healthcare system, emphasizing the importance of keeping UK medical records within a domestically founded platform.
He stressed the core values of trust and transparency embedded in his company, stating, "We approach this with genuine intent to support what could be a once-in-a-generation data transformation."